From diabetes to genetic disorders, gene therapy holds enormous promise. But for every opportunity, there are many obstacles, as we examine in a new white paper. We explore types of gene therapy vectors and look at regulatory and operational challenges associated with these trials, including startup, site selection, recruitment, and retention. Check it out for an insightful look at the pursuit of new treatment breakthroughs.
If you have any questions, and you’re headed to Boston next week, we’ll see you at booth #1110! Premier Research. It’s what we do. Best.